FindTrial
Sign In

Multicenter Retrospective Study of Early Mortality Cases in Neuroblastoma

Multicenter Retrospective Study of Early Mortality Cases in Neuroblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103549
Enrollment
Unknown
Registered
2025-05-30
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroblastoma

Interventions

Observation group:None

Sponsors

Fujian Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: (1) Age <= 18 years; (2) Pathologically confirmed neuroblastoma; (3) Received conventional treatment regimens; (4) Death occurred within 6 months after diagnosis.

Exclusion criteria

Exclusion criteria: (1) Comorbid congenital immunodeficiency disorders;(2) Treatment discontinuation due to personal reasons rather than disease progression.

Design outcomes

Primary

MeasureTime frame
Cause of death;Tumor response to chemotherapy;Time from initial diagnosis to death (days) ;Imaging-defined risk factors;—

Secondary

MeasureTime frame
Age;Tumor location and size;MYCN amplification;Histopathology;Neuron-specific enolase (NSE);Vanillylmandelic acid (VMA);Stage;Surgical Treatment;Chemotherapy;—

Countries

China

Contacts

Public ContactBing Zhang

Fujian Children's Hospita

306365306@qq.com+86 135 5945 5074

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026